Yatharth Hospital & Trauma Care Services Limited will participate in an investor conference organized by Systematix Group on June 16, 2026, in Mumbai. The event, titled the Systematix Promoters & Founders Forum 2026, is part of the company's engagement with the investment community under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The management confirmed that no unpublished price sensitive information will be shared during the meeting.

The schedule for the conference is subject to change based on exigencies faced by the investors or the company. The disclosure regarding this participation has been submitted to the National Stock Exchange of India Limited and BSE Limited.

Investor Conference Details

The following table outlines the specifics of the upcoming event:

The information is also accessible on the company's official investor relations website.

Yatharth Hospital & Trauma Care Services Limited reported a 30% increase in consolidated net profit to ₹1,703 million for the financial year ended March 31, 2026, compared to ₹1,306 million in the previous year. Total revenue from operations surged 36% to ₹12,072 million from ₹8,856 million in FY25, driven by the expansion of its healthcare services and operational ramp-up of new hospitals. Profit after tax for Q4FY26 rose 15% year-on-year to ₹447 million, while revenue for the quarter stood at ₹3,416 million, a 47% increase from ₹2,330 million in the corresponding period of the previous year.

Q4 and FY26 Financial Performance

The board approved the financial results at a meeting held on May 25, 2026. EBITDA for FY26 increased 30% to ₹2,921 million, with an EBITDA margin of 24.2%. For Q4FY26, EBITDA grew 37% year-on-year to ₹799 million, with a margin of 23.4%. The company reported an operating cash flow of ₹2,866 million for FY26, reflecting a cash conversion ratio of 98%, compared to 70% in the previous year. The total cash position stood at ₹3,931 million, with a net cash position of ₹1,160 million.

Operational Expansion

During the fiscal year, the group expanded its operational footprint significantly. A hospital acquired in Model Town, New Delhi, commenced commercial operations on July 14, 2025, with a capacity of 300 beds. Additionally, a hospital in Sector 20, Faridabad, Haryana, started operations on September 22, 2025, featuring 400 beds. The group also began commercial operations at the Shantived hospital in Agra, Uttar Pradesh, on February 1, 2026, with a capacity of 150 beds, expandable up to 250 beds. The recently acquired Gurugram facility is expected to commence operations at the beginning of the next fiscal year.

Key Operational Metrics

The group reported strong operational metrics for the year. Average Revenue Per Occupied Bed (ARPOB) increased to ₹33,283, up 5% year-on-year, driven by an increasing share of high-value specialities. Occupancy levels improved to 68% for FY26, up from 61% in the previous year. Newer hospitals in Greater Faridabad, Faridabad Sector-20, New Delhi, and Agra contributed ₹753 million in revenues, accounting for 22% of the group’s revenues in Q4FY26. Adjusted EBITDA margin, excluding the impact of new hospitals, stood at 30.4% for Q4FY26.

Future Outlook and Strategy

Management expects the total bed capacity to reach over 3,200 beds with upcoming facilities in Gurugram, Noida Extension, and Greater Noida. The company targets a bed capacity of 5,000 over the next three years, with approximately 70% of the expansion expected through acquisitions and 30% through greenfield projects. The Gurugram facility, acquired for an upfront consideration of approximately ₹100 crores, is expected to become operational by April 2027 with an ARPOB exceeding ₹50,000. The company maintains a net cash position of ₹1,160 million as of FY26.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0JO301016/4f20772c50f44391.pdf